If you look at the past year's financials of A2M, they are up in every aspect. See (fig. 1). Compare that to Nestle's finance over the last year, they are down overall from last year by nearly 50% with very little growth. A2M clearly will continue to grow if past results are anything to go by. It's pretty amazing that A2M has managed to scare Nestle one of the biggest food companies in the world into producing A2 protein based products. Holding since $4.50 and will continue to top up.
A2M ↑
Compared to Nestle ↓
- Forums
- ASX - By Stock
- A2M
- nestle - doing A2 infant formula
nestle - doing A2 infant formula, page-69
-
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.86 |
Change
-0.020(0.29%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $5.867M | 848.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 12786 | $6.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 5777 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 14547 | 6.850 |
24 | 35095 | 6.840 |
19 | 36427 | 6.830 |
12 | 20993 | 6.820 |
11 | 14249 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 5697 | 13 |
6.870 | 14942 | 22 |
6.880 | 28280 | 20 |
6.890 | 30002 | 13 |
6.900 | 33076 | 15 |
Last trade - 14.26pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online